Table 3.
Species | Strain | Essential Oil | Reference Antibiotic 1 | ||
---|---|---|---|---|---|
IZD 2 (mm) | MIC 3 (µg/mL) | IZD (mm) | MIC (µg/mL) | ||
S. aureus | ATCC 29213 | 14.3 ± 0.6 | 512 | 20.67 ± 1.15 | 0.25 |
MRSA 4 -19 | 1024–2048 | ||||
MRSA-42 | 512–1024 | ||||
MRSA-75 | 512–1024 | ||||
MRSA-101 | 512–1024 | ||||
E. faecalis | ATCC 29212 | 8.7 ± 0.6 | 4096 | 24.0 ± 2.6 | 0.5–1 |
E. coli | ATCC 25922 | n.a. 5 | N.D. 6 | 19.7 ± 0.6 | 0.016 |
P. aeruginosa | ATCC 27853 | n.a. | N.D. | 21.7 ± 0.6 | 0.5 |
C. albicans | ATCC 24433 | 9.0 ± 1.0 | 512 | 16.33 ± 0.58 | 4.0 |
1 Ciprofloxacin for Gram-positive species, gentamicin for Gram-negative ones; nystatin for C. albicans. 2 IZD, inhibition zone diameter. Each value is an average of three independent experiments with standard errors indicated. 3 MIC; minimum inhibitory concentration. 4 MRSA, Methicillin-Resistant Staphylococcus aureus. 5 n.a., no activity. 6 N.D., not determined.